Former TKT CEO joins Epix
Executive Summary
Michael Astrue takes over as interim CEO of Epix Pharmaceuticals following the resignation of Michael Webb, who will remain involved as a consultant to the company. Astrue, the former CEO of Transkaryotic Therapies, joined the board of Tercica in August (1"The Pink Sheet" Aug. 22, 2005, p. 9)...